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Highlights 
 
 Injectable nanocomposite gels were developed for the co-delivery of two drugs. 
 Drugs with opposite solubility were successfully loaded in the nanoparticles and matrix. 
 The DDS is based on renewable polymers and gelation obtained by enzymatic cross-linking  
 40% curcumin was released over 4 days, compared to 82% from the free nanoparticles 
 
Abstract 
We developed a nanocomposite gel composed of gelatin and poly(3-hydroxybutyrate) polymeric 
nanoparticles (PNP) to be used as an injectable gel for the contemporaneous, dual sustained release 
of bioactive molecules. The hydrogel matrix was formed from a very simple process, using either the 
physical gelation of gelatin or the natural enzyme transglutaminase to covalently cross-link the 
gelatin chains in the presence of embedded PNP. Oscillatory rheological measurements showed that 
the addition of the PNP induced an increase in the storage modulus compared to pure gelatin gels, 
for both physical and chemical gels. Micrographs from scanning electron microscopy revealed that 
the presence of PNP disrupted the native structure of the gelatin chains in the hydrogel matrix. Dual 
drug encapsulation was achieved with curcumin (CM) in the PNP and naproxen sodium in the gelatin 
matrix. In vitro release studies showed that the hydrogel matrix acts both as a physical and chemical 
barrier, delaying the diffusion of the drugs. An initial burst release was observed in the first hours of 
the measurement, and around 90% was released on the third day for naproxen sodium. In free PNP, 
82% of curcumin was relased after four days, while when PNP were embedded in  the gelatin matrix 
only 40% was released over the same time period. Overall, these simple, sustainable soft 
nanocomposites show potential as an injectable co-sustained drug release system. 
 
Keywords: gelatin hydrogels; poly(3-hydroxybutyrate) nanoparticles; soft nanocomposites; 
curcumin; naproxen sodium; dual drug delivery. 
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1. Introduction 
The development of effective drug delivery systems (DDS), which help optimise the drug 
therapeutic effect, while minimizing undesirable side effects, has been the main focus of 
pharmaceutical research over the past couple of decades. A major challenge faced by the 
pharmaceutical industry is the increasing lack of solubility of most drug candidates being 
discovered and the increasing demand to solubilise the drug in an aqueous environment, not 
only for administration, but also for drug development [1]. In addition to improved 
solubilisation, the DDS should improve the pharmacokinetics of the drug, prolong circulation 
times, protect the drug from degradation (chemical, enzymatic, etc), enhance its 
bioavailability and provide sustained release kinetics [2]. In parallel, the growing interest in 
biopharmaceuticals (such as recombinant proteins and antibodies) demands the use of ‘soft’ 
drug delivery matrices that are able to preserve the inherent characteristics of the biological 
molecules (preserving the ternary structure, preventing aggregation etc). The advent of 
nanotechnology has led to the development of a range of suitable DDS, such as polymeric 
nanoparticles, micelles, liposomes or hydrogels [3-7], which, in addition to the 
aforementioned properties, often present responsiveness to external triggers, such as 
temperature or pH, thus affording controlled release and/or loading from the carrier. 
Recently, the increased understanding of cellular mechanisms, identification of multitarget 
drugs, and the discovery of synergistic effect achieved by combining multiple drugs, has led to 
the development of combination therapy, namely, DDS that combine different drugs, thus 
offering improved efficiency[2, 8]. This area is particularly relevant to biopharmaceuticals, 
which often need to be combined to a small-drug, and to the cancer arena [2, 8], where 
combination chemotherapy is becoming increasingly important to maximise therapeutic 
effect while overcoming drug resistance. The combination of anti-inflammatory and anti-
cancer drugs is very promising for cancer therapy because inflammation can affect many 
aspects of tumour development and progression, as well as the response towards the therapy 
[9, 10]. One of the main challenges of combined therapy is to control both the loading and 
the release profile of each drug independently [9-14], and the task is further complicated if 
the therapeutic molecules have vastly different solubility, for instance one is predominantly 
hydrophilic and the other hydrophobic. This requires the use of compartmentalised DDS, with 
solubilisation loci suitable for drugs with vastly different characteristics. On this basis, we 
report here the design of a DDS for combination therapy, based on polymeric nanoparticles 
embedded in a hydrogel matrix. The focus is on the use of sustainable materials and simple, 
low-cost preparation protocols. 
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Hydrogels, usually based on a network of cross-linked polymeric chains, offer a hydrophilic 
three-dimensional structure, mechanical properties and an aqueous environment compatible 
with living tissues, and enable the encapsulation and controlled release of hydrophilic 
therapeutic agents[15-17]. The combination of such a matrix with polymeric nanoparticles – 
in so-called ‘soft nanocomposites’ or ‘nanocomposite gels’ (NC)[18] – offers a simple, 
compartmentalised DDS, with potential for combination therapy. The association of a soft 
hydrophilic matrix with nanoparticles indeed offers a versatile platform for the design of new 
materials, and has been applied to a number of areas[18]: for instance, the incorporation of 
antimicrobial, metal nanoparticles into bulk hydrogels has led to the development of skin 
grafts[19]; intrathecal delivery was demonstrated with nanoparticle-loaded hyaluronan 
NCs[20], and stimuli-responsive gels were achieved by the incorporation of nanoparticles that 
can respond to a magnetic field[21, 22] or irradiation[23, 24] and thus impact the 
characteristics of the whole matrix, such as the release of a payload[23] or the induction of 
mechanical forces able to actuate cells.[25] The myriad of properties achievable from the 
synergy of a hydrophilic matrix and nanoparticles have been discussed in a recent review[18]. 
In this work, we report the preparation and evaluation of a dual delivery matrix based on a 
nanocomposite gel of enzymatically cross-linked gelatin and embedded poly(3-
hydoxybutyrate) nanoparticles. We have assessed the co-encapsulation of two hydrophilic 
and hydrophobic drugs: naproxen sodium, a non-steroidal anti-inflammatory drug (NSAID),[26] 
solubilised in the hydrogel matrix, and curcumin, a hydrophobic polyphenol derived from 
turmeric, which displays anti-oxidant, anti-inflammatory and anticancer properties,[27-29] and 
was loaded into the polymeric nanoparticles. Gelatin is a biopolymer, derived from the partial 
hydrolysis of collagen and widely used in biomedical applications due to its excellent 
biodegradability and biocompatibility.[30, 31] In this paper, it is cross-linked with the natural 
enzyme microbial transglutaminase (mTGase), which preserves the biocompatibility and 
immunogenicity of the original material [32]. For the nanoparticles, poly(3-R-
hydroxybutyrate) (PHB) was used, the principal representative of bacterial 
polyhydroxyalkanoates (PHAs), which offer a competitive alternative to conventional 
synthetic polymers such as polypropylene, polyethylene and polyesters. These polymers are 
nontoxic and renewable. Their biotechnology output does not depend on hydrocarbon 
production and their biodegradation intermediates and resulting products (water and carbon 
dioxide) do not provoke adverse reactions in environmental media or living systems [33-35]. 
We evaluated the rheological properties of the nanocomposite gels and measured the 
combined release of the two drugs. Overall, the system we propose offers a simple, cheap 
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and sustainable approach to combination therapy with drugs displaying opposite solubility 
characteristics.  
2. Experimental 
2.1 Materials 
Gelatin. Fish gelatin was donated by Rousselot, France. All experiments were carried out 
using a single batch of gelatin (from 2008). The gelatin was extracted from tilapia fish skin by 
an acidic process, and possesses an isoelectric point pI ̴ 8-9, bloom strength of 275, and a 
gelation temperature of ca. 23°C at the concentration used. The average molecular weight 
was determined as ∼36 kDa ± 12% by GPC (Smithers Rapra). Enzyme. The cross-linker used in 
this study was microbial transglutaminase (mTGase), obtained from N-Zyme BioTec 
(Darmstadt, Germany) (specific activity: 1.6 U-mg solid; molecular weight: 38 kDa; purity 
>80%). The enzyme is stable between pH 5-9, and 0-40 °C. Poly(3-hydroxybutyric acid). The 
polymer was donated by PHB Industrial S-A, Usina da Pedra s-n – Serrana, São Paulo, Brazil. 
The poly(-3-hydroxybutyric acid) is of natural origin, molecular weight around 600,000 (from 
GPC), melting point  ̴ 170 °C, and negligible solubility in water. Drugs. Naproxen sodium, ≥ 
98.0% purity (CAS number 26159-34-2) was obtained from Sigma-Aldrich and curcumin, 95% 
purity (CAS number 458-37-7, was obtained from Santa Cruz Biotechnology, USA. Other 
chemicals. Organic solvents: 2-propanol, acetone and dichloromethane were obtained from 
Sigma-Aldrich. Phosphate buffered saline and Tween 80 were obtained from Sigma-Aldrich. 
Pluronic F68 (F68) was obtained from MP Biomedicals.  
 
 
 
 
Preparation of the Polymeric Nanoparticles (PNP) 
2.2 Poly(3-hydroxybutyrate) (PHB) nanoparticles.  
Nanoparticles were prepared by the solvent displacement method.[36, 37] PHB was 
solubilized in dichloromethane to a concentration of 5 mg mL-1. This stock solution was added 
drop-wise under magnetic stirring at 800 rpm into an alcoholic solution (2-propanol 
containing 1% w/w of Tween 80). The system was left overnight in the fume hood under 
magnetic stirring to eliminate dichloromethane excess. The particles were centrifuged (8000 
rfc) and the supernatant removed. The particles were dispersed in ultrapure water (18.2 MΩ 
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cm) and freeze-dried for at least 24 hours. The freeze-dried powder was kept in the freezer 
until use. 
 
2.3 Curcumin-loaded Polymeric Nanoparticles  
The physical encapsulation of curcumin was carried out using the solvent displacement 
method described above. Instead of the pure polymer, a PHB-curcumin solution was made in 
dichloromethane with a final PHB concentration of 5 mg mL-1 and 50 µg mL-1 of curcumin.  
 
2.4 Entrapment efficiency (EE) and Drug loading (DL).  
The amount of curcumin entrapped into the PNP was determined by measuring the 
amount of curcumin remaining in the supernatant after centrifugation. The difference 
between the initial amount and the free amount in the supernatant provides the entrapment 
efficiency of curcumin into the PNP. Drug concentration was measured in triplicates by a 
validated UV-Vis method. [38, 39] 
Drug loading determination was performed through the dissolution of a known amount of 
freeze-dried powder in dichloromethane. The determination of the amount of curcumin in 
the PNP was performed as follows: 5 mg of the freeze-dried particles containing the drug was 
solubilized in 5 mL of dichloromethane and incubated at 37 °C for 2 hours in a sealed vial and 
covered with foil. The curcumin concentration was determined by UV–Vis using a standard 
calibration curve of curcumin prepared under identical conditions. 
 
 
Preparation of the Gelatin-PNP Hydrogels 
2.5 Gelatin-PNP dispersions. 
Gelatin stock solutions were prepared as follow: 20% w/w gelatin in phosphate buffered 
saline (PBS) was left to swell overnight (pH 7.4) at 4 °C. Before use, the solutions were 
incubated in a water bath at 37 °C for 30 min. 
Four samples with final composition of 10% w/w gelatin and 0, 1, 2 and 4% w/w PHB 
nanoparticles were prepared. Pluronic F68 was added into the sample containing the 
nanoparticles to improve the stability of the dispersion of the PNP in the gelatin and decrease 
aggregation. The final composition of F68 was 2% w/w. The samples were then placed in an 
ultrasonic bath for 10 minutes. The gelatin-PNP dispersions were prepared in triplicates.  
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2.6 Preparation of the Physical Nanocomposite Gels (PG) 
Gelatin forms physical gels when lowering the temperature below the melting point (ca. 
23°C for Tilapia gelatin) through the formation of triple-helices, which act as cross-links in the 
network[40]. To perform rheological measurements on the physical nanocomposite gels, the 
Gelatin-PNP dispersions were loaded onto the rheometer in the sol state at 25 °C (above 
melting temperature), and rheological measurements were started upon a step-decrease of 
the temperature to 21 °C (below melting temperature). The temperature was controlled by a 
Peltier unit (with a cooling rate of ca. 30 °C/min). The nomenclature used for the samples is: 
PG0, PG1, PG2 and PG4, to denote physical gels (PG) with 0, 1, 2 and 4% w/w of PHB particles. 
 
2.7 Preparation of the Chemical Nanocomposite Gels (CG) 
Chemical networks were formed in the presence of the enzyme mTGase, as described 
previously.[32, 40, 41] The required volume of mTGase stock solution was added to the 
previously gelatin-PNP dispersions to achieve a final enzyme concentration of 20 U mTGase/g 
of gelatin. Samples were rapidly vortex-mixed and then loaded onto the rheometer plate 
preheated at 37 °C. It is estimated that around one minute elapsed between the addition of 
mTGase to the sample and the start of the measurements. The nomenclature used for these 
samples is: CG0, CG1, CG2 and CG4, to denote chemical gels (CG) with 0, 1, 2 and 4% w/w of 
PHB particles. 
 
Preparation of the dual release nanocomposite gels 
2.8 Loading of naproxen sodium in the DDS 
The nanocomposites all comprised 10% w/w gelatin and 4% w/w curcumin (CM)-loaded 
polymeric nanoparticles (prepared as described in section 2.3). Naproxen sodium (NS) was 
directly added into the gelatin-PNP dispersion before performing the enzymatic cross-linking. 
The sample was then placed in a mild ultrasonic bath for 10 minutes. Following this, the 
chemical networks were formed by adding the enzyme mTGase in a water bath at 37 °C. 
Figure 2 (c, d and e) schematically describes the preparation of the dual-drug-loaded 
nanocomposites gel, referred to as ‘Gelatin(NS)-PNP(CM)’. These were prepared in triplicates 
for the in vitro-release study.  
 
2.9 In-vitro co-sustained drug release  
For in-vitro release studies, the Gelatin(NS)-PNP(CM) nanocomposite gels were transferred 
to a dialysis tube (1kDa cut-off) (Sigma Aldrich). The dialysis tube was sealed and immersed in 
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15 mL PBS:ethanol release medium (8:2 volume ratio), under continuous magnetic stirring at 
37 ◦C. At specified time intervals, 0.2 mL of solution was drawn from the release medium and 
replaced by 0.2 mL fresh PBS:ethanol solution. The amount of drugs in the release medium 
was quantified by UV-Vis spectroscopy using calibration curves established with the same 
solvent composition. 
Characterization 
Rheology. Rheological measurements were carried out on a strain-controlled ARES 
rheometer (TA Instruments) using parallel plate geometry (25 mm diameter) and the 
temperature was controlled by a Peltier unit (± 0.1 °C). To prevent loss of solvent due to 
evaporation, we applied a thin layer of paraffin oil around the samples, and geometry-covers 
were placed around the plates. To study the build-up of the storage (G’) and loss (G’’) moduli 
upon gelation, time sweep-cure experiments were performed at a fixed frequency of 6.28 
rad/s and strain of 1%. The gel point was established as the time when G’ reaches the 
arbitrarily defined value of 1 Pa [42]. 
Dynamic light scattering (DLS). DLS measurements to determine the average size and size 
distribution of the nanoparticles were performed using a Nanosizer 90ZS (Malvern 
Instruments, Southborough, MA). All data analysis was performed in automatic mode and 
samples measured in triplicates.  
Scanning electron microscopy (SEM). The size and morphology of the PHB nanoparticles 
were evaluated by scanning electron microscopy (Zeiss LEO 440). Freeze-dried 
nanocomposite chemical gels with 10% w/w gelatin and 0, 1, 2, 4% w/w PHB nanoparticles 
were prepared for scanning electron microscopy measurements. Discs of freeze-dried gels 
were cut off and mounted onto stubs using double-sided carbon tape. Gold was coated in a 
sputter coater and the cross-section morphologies of the nanaocomposite gels were 
examined using a Fei Quanta 200 Field Emission Gun.  
UV–Vis spectroscopy. The release of the drugs from the nanocomposite gels was 
performed with UV-Vis spectroscopy (Perkin Elmer UV-Vis Spectrophotometer Lambda 2) at 
the absorbance maximum: 432 nm (curcumin) and 231 nm (naproxen sodium). Calibration 
curves were constructed in the relevant medium to measure entrapment efficiency, drug 
loading and drug release. 
Release mechanism studies. To describe the release behaviour, an empirical power law 
equation proposed by Peppas et al.[43, 44] was used: 
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𝑀𝑡
𝑀∞
= 𝑘𝑡𝑛                                                   (1) 
𝑙𝑜𝑔 (
𝑀𝑡
𝑀∞
) = 𝑙𝑜𝑔𝑘 + 𝑛 log 𝑡                                   (2) 
where Mt and M∞ are the absolute cumulative amount of drug released at time t and 
infinite time, respectively, k is a constant incorporating structural and geometric 
characteristics of the device, and n is the release exponent, indicative of the mechanism of 
drug release. 
3. Results and discussion 
3.1 Preparation of Gelatin-PNP nanocomposite gels 
The PHB nanoparticles were prepared by the solvent displacement method.[36, 45] This 
method is based on the precipitation of a preformed polymer from an organic solution and 
the diffusion of the organic solvent in the medium. The medium can be an aqueous solution 
(with or without surfactants) or an organic solution (provided it is not a good solvent for the 
preformed polymer).[37] Figure 1 shows SEM images of the PHB nanoparticles prepared by 
this method. The inset presents the distribution of sizes obtained from DLS measurements, 
showing an average size of 216 nm with a size distribution from 164 to 295 nm, 
corresponding to a polydispersity of 11%. 
 
 
The nanocomposites were prepared from gelatin, freeze-dried nanoparticles and F68 (1%) 
in PBS solution, as described in the experimental section. Figure 2 shows the appearance of 
the gelatin-PNP hydrogels with increasing amounts of particles prepared from the chemical 
protocol. Figure 2(a) shows the appearance of the gelatin-PNP nanocomposite gels in the 
hydrated state, straight after preparation and Figure 2(b) shows the same samples after the 
freeze-drying process. Sample 5 is the drug loaded nanocomposite gel, Ge nanocomposites of 
gelatin and poly(3-hydroxybutyrate) nanoparticles for dual drug release latin(NS)-PNP(CM), 
which was further tested for in vitro drug release. 
 
 
Figure 3 reports the evolution of the storage (G’) and loss moduli (G’’) as a function of PHB 
nanoparticle-loading of the nanocomposite gels prepared from the enzymatic cross-linking 
process (chemical protocol). The time sweeps show a relatively sharp increase of both moduli 
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over the first few minutes of the measurements, reflecting the cross-linking process, followed 
by a near-plateau region, where only a very slight increase in mechanical properties is 
observed. Both time and frequency-sweeps measurements reveal some differences with 
particle loading. Gelatin also displays a natural, temperature-induced gelation process, which 
occurs through the formation of triple-helices (reminiscent of the native collagen), which act 
as junction points for the network. For comparison purposes, time and frequency sweep 
measurements of the gelatin-PNP nanocomposites obtained from the physical gelation 
process are shown in supporting information (Figure S1).The storage modulus (G’) and 
gelation times after 180 min for samples prepared by the physical and chemical protocols are 
shown in Table I. The storage modulus shows a dependence on the amount of PNP 
embedded in the matrix: the higher the amount of PNP, the higher the value of G’, reflecting 
increasing elasticity of the gels with particle loading. The introduction of PHB nanoparticles at 
1% w/w induces a slight increase in the storage modulus, when compared with the pristine 
gelatin. A further increase in the concentration of nanoparticles (up to 4% w/w) increases the 
storage modulus to a larger extent, both for the physical and the chemical protocols, while 
not affecting the solid-like vs liquid-like properties (tan ()). This increase in mechanical 
properties by the introduction of nanoparticles is not surprising [46] and may result from an 
increase in connectivity arising from gelatin-particles interactions or an increased cross-
linking between gelatin chains, caused by a higher effective concentration due to the 
presence of particles (either enhancing triple-helix formation for the physical gels, or covalent 
bonding from the chemical process). The presence of the nanoparticles also reduces the 
gelation time, down to <30% of the original time at the highest loading for the physical gels 
and ca. 44% for the chemical gels (Table I). Overall, the nanoparticles have a similar effect on 
the gel properties, using either type of gelation protocol (chemical or physical). For practical 
applications however, the enzymatic cross-linking process is the only viable process and leads 
to gelation times (below 10 min), which are suitable for injectable gels. Therefore, in the 
following, we focus on the evaluation of the enzymatic cross-linking process. 
 
 
3.2 Microstructure of the gelatin-nanoparticles hybrid gels -Chemical protocol 
Information on the structure was obtained from electron microscopy on the freeze-dried 
gels, with and without nanoparticles. Figure 4(a) shows the micrographs of the gelatin sample 
(CG0), which consists in a lightly etched surface with hollow arrays interconnected by thin 
walls. This structure is characteristic of the morphology of pristine gelatin.[47] 
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The presence of PNP disrupts the native structure of the gelatin microstructure. Each 
concentration of the PNP provides different structures. Figures 4(b), 4(c) and 4(d) show the 
morphology from samples CG1, CG2 and CG4, respectively. With 1 % w/w PNP (CG1), it is still 
possible to see the lightly etched gelatin microstructure, as shown in Figure 4(b). At the 
highest loading of 4 % w/w PNP, CG4 appears quite different from the other samples. Figure 
4(d) shows a highly porous gelatin–PNP hybrid, which presents a heterogeneous surface 
texture with large pores and interconnections. Porous structures allow the water to be 
expelled or absorbed by convection, a much faster process than by diffusion.[48] This 
structure formed by the combination of a gel matrix with nanoparticles may explain the 
increase in storage modulus when compared to pristine gelatin. Agglomerates of PNP were 
observed in the cross-sectional areas in all samples. The presence of segregated PNP is mainly 
observed in CG1 and CG2, which are shown in Supplementary Figure S3, S4 and S5. 
 
 
 
In vitro Drug Release Studies 
Following the encapsulation of both drugs, in vitro co-sustained release from the 
nanocomposite was measured. Curcumin was encapsulated in the PNP with 52% entrapment 
efficiency, whereas naproxen sodium was directly incorporated in the gelatin matrix. 
Simultaneous detection of naproxen and curcumin released in the medium from the 
nanocomposite gels was performed by UV-Vis absorbance, since their absorbance maxima 
are well separated. 
Figure 5(a) shows the sustained release of naproxen from the gelatin-PNP hydrogel. An 
initial burst release was observed in the first hours of the measurement, and around 90% was 
released on the third day. The released from the gel was much slower than the free drug 
diffusing through the membrane, which was complete in less than 24 hours.  
Figure 5(b) compares the sustained release of curcumin from the PNP, either in the gel 
matrix or in solution. An initial burst release of curcumin was observed in both samples. In the 
free PNP, over 82 % of curcumin was released after 48 hours (red curve). The hybrid system 
(gelatin-PNP, black curve) provides a delay in drug release compared to the free PNP. After 
four days of measurement, over 90% of CM was released from the system containing PNP 
only, whereas only ca. 40% was released when the PNP are embedded in the gel matrix. After 
seven days, still only 52% of curcumin was released, while naproxen release was complete 
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between the third and fourth day. Thereby, the hydrogel further delays the release from the 
nanoparticles that are embedded in the matrix.  
The release profile was analysed by the model described by Peppas[43, 44, 49]. The kinetic 
constant and release exponent obtained from fitting the curves to this model are shown in 
Supplementary Table SI. The release of curcumin from the free PNP proceeds via an 
anomalous transport process, whereby the drug is released by a complex mechanism, 
namely, a mixture of Fickian diffusion and surface degradation of the matrix. However, in the 
presence of gelatin, the release of curcumin follows a Fickian diffusion profile. For naproxen, 
the release exponent indicates an anomalous transport model. In the gelatin sample, besides 
drug diffusion, surface degradation is a heterogeneous process in which degradation (and 
subsequent erosion) is confined to a thin surface layer of the biopolymer[49]. 
 
 
Applicability of the nanocomposites as an injectable, dual-delivery matrix 
In order to assess the potential of the nanocomposites as injectable gel formulations, a 
preliminary evaluation of their storage as a frozen formulation was performed. The gelatin-
PNP dispersion (1% PNP) was kept in the freezer at -20 °C over a period of several days. The 
sample was then warmed up to 37◦C in a water bath, and mTgase (20 U/g) quickly added and 
mixed into the gelatin-PNP dispersion (Supporting Information, S2). The chemical 
nanocomposite gel presented the same rheology profile than a freshly prepared 
nanocomposite gel (SI), with only a small decrease in the storage modulus, which remained of 
the same order of magnitude (ca. 3,5 kPa). Injection with a hypodermic syringe was also 
performed as proof-of-concept, following rapid mixing of mTGase and gelatin solutions, and 
showed that the viscosity of the pre-gelation mixture was suitable for injection, i.e. did not 
required excessive pressure. 
Our previous results on the gel matrices using F-actin staining (cell spreading and morphology), cell 
compatibility (LIVE/DEAD assay) and proliferation (MTS) assays on MC3T3 osteoblast cell lines[41],  
as well as cell compatibility (AlamarBlue) and proliferation assays (MTS/MTT assays) on rat bone-
marrow mesenchymal stem cells (rBMSCs)[32] showed that the crosslinked gelatin matrix was not 
cytotoxic and supported cell proliferation. PHB based micro- and nano- carriers have been reported 
for the delivery of various drugs; PHB is degraded in vivo through both enzymatic and non-enzymatic 
processes under normal conditions [50, 51, 52]. In vivo testing of the nanoparticles will be the subject 
of future work. 
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Conclusions 
A dual drug delivery system that can load and release different drugs in a controlled 
manner is a strategy that has been attracting increased interest over the past few years. The 
nanocomposite reported in this study, comprising curcumin-loaded PHB nanoparticles 
embedded in a gelatin matrix with solubilised naproxen sodium, provides a sustainable, 
cheap and simple approach. Two gelation processes were evaluated: physical gelation (due to 
the formation of triple helices at low temperatures) and chemical cross-linking (obtained with 
the enzyme transglutaminase, which thus does not compromise the biocompatibility of the 
original material). The incorporation of PHB nanoparticles in the gelatin matrix did not 
interfere with the formation of the gel. Increasing the concentration of nanoparticles (from 1 
to 4 % w/w) resulted in an increase in storage modulus and a decrease in gelation time, with 
both the physical and chemical protocols. Scanning-electron microscopy images showed that 
the presence of PNP disrupted the native structure of the gelatin chains, showing a 
heterogeneous surface texture with large pores and interconnections. 
Curcumin was successfully loaded into the PHB nanoparticles, with an entrapment 
efficiency around 52%, while naproxen sodium was concomitantly solubilised in the gelatin 
matrix. In vitro studies of the co-sustained release of naproxen and curcumin from the 
nanocomposite gels obtained from the chemical cross-linking process showed that the 
hydrogel matrix acts as a physical and chemical barrier delaying the diffusion of both drugs. 
After four days, only 40% of curcumin was released from the hybrid gels, compared to 82% 
from the free PNP.  
The gelatin-PNP dispersion can be frozen, warmed-up and mixed with transglutaminase, 
displaying the same rheological properties as a freshly prepared sample, and is easily 
injectable through a hypodermic syringe. Based on the demonstrated biocompatibility of the 
starting materials, this work opens up the possibility of using the nanocomposites as in-situ 
gelling, injectable formulations, for instance using a double-barrel syringe. These soft 
nanocomposites offer simultaneous, sustained release for both a hydrophobic and a 
hydrophilic drug over a long period of time, and thus present potential as a sustainable, dual 
drug-loading matrix.  
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Figure 1. (a) SEM microphotographs of the PHB nanoparticles prepared by the solvent 
displacement method. Scale bar: 200 nm. (b) Size distribution by intensity obtained from DLS. 
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Figure 2. Pictures showing the appearance of the gelatin-PNP chemical gels containing 10% 
w/w gelatin and 4% w/w polymeric nanoparticles loaded with curcumin: (a) at room 
temperature and (b) after freeze-drying. Samples code: 1: CG0, 2: CG1, 3: CG2, 4: CG4 and 5: 
nanocomposite CG4 loaded with naproxen sodium and curcumin. 
 
 
 
Figure 3. (a) Time and (b) frequency sweep measurements of the nanocomposite gels 
prepared from the chemical protocol (CG) with 10 (CG0), 20 (CG1), 30 (CG3) and 40 (CG4) mg 
of nanoparticles /g of gelatin. The inset in (a) shows an expanded part of the time sweep 
measurements to highlight differences at varying PNP loadings. The storage modulus (G’) is 
represented by filled symbols and loss modulus (G’’) with open symbols.  
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Figure 4. Microstructure of the gels obtained from electron microscopy on the freeze-dried 
samples. (a) CG0 (pure gelatin); and gelatin-nanoparticles hybrid gels: (b) CG1; (c) CG2; (d) 
CG4. 
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Figure 5. Sustained release of (a) naproxen sodium and (b) curcumin from the Gelatin-PNP 
hydrogel obtained by enzymatic cross-linking (black dots) and from the PNP (red dots). Lines 
are guides to the eye. 
 
 
Table I. Values of the final storage modulus and gelation times of the gelatin-PNP hybrid gels 
submitted either to a physical (PG) or a chemical cross-linking process (CG). 
network type samples G’ a(Pa)/ SDb(%) tan (δ) t gelation (min) 
     
Physical 
Protocol 
PG0 1935/5.4 0.03596 1.4 
PG1 2285/3.5 0.03937 0.8 
PG2 2631/8.5 0.03357 0.5 
PG4 3189/4.8 0.04366 0.4 
     
Chemical 
Protocol 
CG0 3434/1.0 0.00725 8.3 
CG1 4607/1.0 0.00653 5.2 
CG2 5357/7.3 0.00922 4.8 
20 
 
CG4 6220/9.1 0.00360 3.7 
     
a. Mean G’ value of three measurements; b. SD = standard deviation relative to the mean; c. mean of 
three measurements. 
 
 
